66 filings
Page 4 of 4
8-K
gdzwd
21 Jun 19
Applied Therapeutics Reports First Quarter 2019 Financial Results
7:34am
8-K
4ofg6wap0csk 5gu
7 Jun 19
AT-001, a novel, potent and selective aldose reductase inhibitor, is expected to start a pivotal study later this year
7:59am
8-K
g9k8vb jjvup
6 Jun 19
Departure of Directors or Certain Officers
4:05pm
8-K
h9c7fb6g437zu
28 May 19
Applied Therapeutics Announces Fda Orphan Drug Designation for AT-007 In Galactosemia
5:14pm
8-K
1bq99w7ghxsg2vd s5mi
24 May 19
Other Events
4:24pm
8-K
1l6z4nuh9g 1xff
16 May 19
Amendments to Articles of Incorporation or Bylaws
5:22pm